Migraine Headaches and Botox Injection

Added 30 May, 2017
Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedInEmail this to someonePrint this page

PRESENTING COMPLAINT

The patient presented with severe headaches, occurring on a daily basis. Headaches had been persistent for several years, but worse over the past 18 months. Patient experienced nausea and photophobia during headaches.

Patient’s headaches were diagnosed as migraines by the neurologist.


PREVIOUS INVESTIGATIONS/ TREATMENTS

The patient had seen the neurologist in the past who investigated her with CT scan of the brain and this was reported as normal.

The patient tried various medications including prophylactic drugs like Propranolol, Gabapentin, Amitriptyline and Topiramate without benefit. The patient was taking oral analgesics including Paracetamol, Codeine Phosphate and Sumatriptan to control the headaches.


TREATMENT FROM DR. KRISHNA AT PAIN SPA

The patient saw Dr. Krishna at his private clinic in Bristol, desperate for some control of her migraine headaches. Dr. Krishna confirmed the diagnosis of migraine and offered treatment with Botox as per NICE protocol.


OUTCOME

The patient had an excellent response to Botox treatment, with a significant reduction in frequency as well as the intensity of her headaches. The patient had a repeat treatment after 4 months with a similar response. The patient managed to reduce the intake of oral analgesics significantly following treatment with Botox.

Have a question? Or would like to book in with us?

Get in Touch

Common Conditions
that we Treat Everyday

View All Conditions

Latest from the Blog

Posted 14 Oct, 2017

When the Last Resort Fails: Failed Back Surgery Syndrome

Las Vegas—Surgery is a last resort in seeking relief for chronic low back pain—the most common cause of disability—but unsuccessful surgery occurs often enough to warrant its own diagnostic code as failed back surgery syndrome (FBSS). The condition was examined in a well-attended session at the recent PAINWeek 2017 ann...
Posted 14 Oct, 2017

FDA Asks, Gets Answers on Reducing Opioid Epidemic

The prevalence and consequences of opioid use disorder can be reduced without preventing patients with pain from receiving necessary opioid analgesics, according to a consensus report from the National Academies of Sciences, Engineering, and Medicine requested by the FDA. The report, issued July 13, distinguishes its f...
Posted 02 Oct, 2017

The chronic pain that won’t go away: CRPS

CRPS is a rare neurological condition that causes unending agony and misery. But now a special implant offers hope to sufferers. What’s it like to have a pain that just won’t go away? Complex regional pain syndrome, or CRPS, causes exactly that, and it’s as hard to diagnose as it is to understand. It can […]